VCYT — Veracyte Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapFalling Star

Annual balance sheet for Veracyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	349	173	179	216	289
Net Total Accounts Receivable
Net Total Receivables	18.5	41.5	44	40.4	46.5
Total Inventory
Prepaid Expenses
Total Current Assets	376	243	249	286	372
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16.8	31.1	30.9	30.9	71.1
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	457	1,188	1,156	1,115	1,300
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	16.8	64.2	62.6	61.2	78.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	35.9	91.3	81.2	70.8	124
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	421	1,097	1,075	1,044	1,176
Total Liabilities & Shareholders' Equity	457	1,188	1,156	1,115	1,300
Total Common Shares Outstanding